Expression and activation of a C-terminal truncated isoform of STAT5 (STAT5Δ) following interleukin 2 administration or AZT monotherapy in HIV-infected individuals

Chiara Bovolenta, Laura Camorali, Massimiliano Mauri, Silvia Ghezzi, Silvia Nozza, Giuseppe Tambussi, Adriano Lazzarin, Guido Poli

Research output: Contribution to journalArticle

Abstract

Intermittent administration of recombinant interleukin-2 (rIL-2) to individuals infected with human immunodeficiency virus (HIV) has been shown to raise and maintain the absolute number of circulating CD4+ T cells to normal or near normal levels. One of the signaling pathways triggered by IL-2 is the Janus kinase-signal transducer and activator of transcription (JAK-STAT). In particular, IL-2 activates the tyrosine kinases JAK1 and JAK3 and the transcription factors STAT3 and STAT5. We have previously observed that most HIV+ individuals, unlike healthy seronegative controls, show a constitutive activation of STAT1 and a C-terminal truncated isoform of STAT5 (STAT5Δ). In the present study, we have analyzed the protein level and activation state of STAT5 isoforms expressed in peripheral blood mononuclear cells of two HIV-infected individuals who showed a good or a poor response to intermittent IL-2 administration, respectively, and of a single individual before and after initiation of Zidovudine monotherapy. We provide evidence that both therapeutic interventions enhanced the expression and activation of the C-terminal truncated isoform of STAT5 (STAT5Δ) in vivo.

Original languageEnglish
Pages (from-to)75-81
Number of pages7
JournalClinical Immunology
Volume99
Issue number1
DOIs
Publication statusPublished - 2001

Fingerprint

Interleukin-2
Protein Isoforms
HIV
STAT5 Transcription Factor
Janus Kinases
STAT3 Transcription Factor
Zidovudine
Transducers
Protein-Tyrosine Kinases
Blood Cells
T-Lymphocytes
Proteins
Therapeutics

Keywords

  • AIDS/HIV
  • AZT
  • IL-2
  • Immunotherapy
  • STAT

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Pathology and Forensic Medicine

Cite this

Expression and activation of a C-terminal truncated isoform of STAT5 (STAT5Δ) following interleukin 2 administration or AZT monotherapy in HIV-infected individuals. / Bovolenta, Chiara; Camorali, Laura; Mauri, Massimiliano; Ghezzi, Silvia; Nozza, Silvia; Tambussi, Giuseppe; Lazzarin, Adriano; Poli, Guido.

In: Clinical Immunology, Vol. 99, No. 1, 2001, p. 75-81.

Research output: Contribution to journalArticle

@article{8dc84b15bc7d4d8abddd69e2122e26a8,
title = "Expression and activation of a C-terminal truncated isoform of STAT5 (STAT5Δ) following interleukin 2 administration or AZT monotherapy in HIV-infected individuals",
abstract = "Intermittent administration of recombinant interleukin-2 (rIL-2) to individuals infected with human immunodeficiency virus (HIV) has been shown to raise and maintain the absolute number of circulating CD4+ T cells to normal or near normal levels. One of the signaling pathways triggered by IL-2 is the Janus kinase-signal transducer and activator of transcription (JAK-STAT). In particular, IL-2 activates the tyrosine kinases JAK1 and JAK3 and the transcription factors STAT3 and STAT5. We have previously observed that most HIV+ individuals, unlike healthy seronegative controls, show a constitutive activation of STAT1 and a C-terminal truncated isoform of STAT5 (STAT5Δ). In the present study, we have analyzed the protein level and activation state of STAT5 isoforms expressed in peripheral blood mononuclear cells of two HIV-infected individuals who showed a good or a poor response to intermittent IL-2 administration, respectively, and of a single individual before and after initiation of Zidovudine monotherapy. We provide evidence that both therapeutic interventions enhanced the expression and activation of the C-terminal truncated isoform of STAT5 (STAT5Δ) in vivo.",
keywords = "AIDS/HIV, AZT, IL-2, Immunotherapy, STAT",
author = "Chiara Bovolenta and Laura Camorali and Massimiliano Mauri and Silvia Ghezzi and Silvia Nozza and Giuseppe Tambussi and Adriano Lazzarin and Guido Poli",
year = "2001",
doi = "10.1006/clim.2001.5005",
language = "English",
volume = "99",
pages = "75--81",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Expression and activation of a C-terminal truncated isoform of STAT5 (STAT5Δ) following interleukin 2 administration or AZT monotherapy in HIV-infected individuals

AU - Bovolenta, Chiara

AU - Camorali, Laura

AU - Mauri, Massimiliano

AU - Ghezzi, Silvia

AU - Nozza, Silvia

AU - Tambussi, Giuseppe

AU - Lazzarin, Adriano

AU - Poli, Guido

PY - 2001

Y1 - 2001

N2 - Intermittent administration of recombinant interleukin-2 (rIL-2) to individuals infected with human immunodeficiency virus (HIV) has been shown to raise and maintain the absolute number of circulating CD4+ T cells to normal or near normal levels. One of the signaling pathways triggered by IL-2 is the Janus kinase-signal transducer and activator of transcription (JAK-STAT). In particular, IL-2 activates the tyrosine kinases JAK1 and JAK3 and the transcription factors STAT3 and STAT5. We have previously observed that most HIV+ individuals, unlike healthy seronegative controls, show a constitutive activation of STAT1 and a C-terminal truncated isoform of STAT5 (STAT5Δ). In the present study, we have analyzed the protein level and activation state of STAT5 isoforms expressed in peripheral blood mononuclear cells of two HIV-infected individuals who showed a good or a poor response to intermittent IL-2 administration, respectively, and of a single individual before and after initiation of Zidovudine monotherapy. We provide evidence that both therapeutic interventions enhanced the expression and activation of the C-terminal truncated isoform of STAT5 (STAT5Δ) in vivo.

AB - Intermittent administration of recombinant interleukin-2 (rIL-2) to individuals infected with human immunodeficiency virus (HIV) has been shown to raise and maintain the absolute number of circulating CD4+ T cells to normal or near normal levels. One of the signaling pathways triggered by IL-2 is the Janus kinase-signal transducer and activator of transcription (JAK-STAT). In particular, IL-2 activates the tyrosine kinases JAK1 and JAK3 and the transcription factors STAT3 and STAT5. We have previously observed that most HIV+ individuals, unlike healthy seronegative controls, show a constitutive activation of STAT1 and a C-terminal truncated isoform of STAT5 (STAT5Δ). In the present study, we have analyzed the protein level and activation state of STAT5 isoforms expressed in peripheral blood mononuclear cells of two HIV-infected individuals who showed a good or a poor response to intermittent IL-2 administration, respectively, and of a single individual before and after initiation of Zidovudine monotherapy. We provide evidence that both therapeutic interventions enhanced the expression and activation of the C-terminal truncated isoform of STAT5 (STAT5Δ) in vivo.

KW - AIDS/HIV

KW - AZT

KW - IL-2

KW - Immunotherapy

KW - STAT

UR - http://www.scopus.com/inward/record.url?scp=0035047539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035047539&partnerID=8YFLogxK

U2 - 10.1006/clim.2001.5005

DO - 10.1006/clim.2001.5005

M3 - Article

C2 - 11286543

AN - SCOPUS:0035047539

VL - 99

SP - 75

EP - 81

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 1

ER -